137 related articles for article (PubMed ID: 12591278)
1. Abnormal splicing of SHP-1 protein tyrosine phosphatase in human T cells. Implications for lymphomagenesis.
Ma XZ; Jin T; Sakac D; Fahim S; Zhang X; Katsman Y; Bali M; Branch DR
Exp Hematol; 2003 Feb; 31(2):131-42. PubMed ID: 12591278
[TBL] [Abstract][Full Text] [Related]
2. RNA hyperediting and alternative splicing of hematopoietic cell phosphatase (PTPN6) gene in acute myeloid leukemia.
Beghini A; Ripamonti CB; Peterlongo P; Roversi G; Cairoli R; Morra E; Larizza L
Hum Mol Genet; 2000 Sep; 9(15):2297-304. PubMed ID: 11001933
[TBL] [Abstract][Full Text] [Related]
3. The SH2 domain-containing protein tyrosine phosphatase SHP-1 is induced by granulocyte colony-stimulating factor (G-CSF) and modulates signaling from the G-CSF receptor.
Ward AC; Oomen SP; Smith L; Gits J; van Leeuwen D; Soede-Bobok AA; Erpelinck-Verschueren CA; Yi T; Touw IP
Leukemia; 2000 Jul; 14(7):1284-91. PubMed ID: 10914554
[TBL] [Abstract][Full Text] [Related]
4. Src homology region 2 (SH2) domain-containing phosphatase-1 dephosphorylates B cell linker protein/SH2 domain leukocyte protein of 65 kDa and selectively regulates c-Jun NH2-terminal kinase activation in B cells.
Mizuno K; Tagawa Y; Mitomo K; Arimura Y; Hatano N; Katagiri T; Ogimoto M; Yakura H
J Immunol; 2000 Aug; 165(3):1344-51. PubMed ID: 10903736
[TBL] [Abstract][Full Text] [Related]
5. Murine SHP-1 splice variants with altered Src homology 2 (SH2) domains. Implications for the SH2-mediated intramolecular regulation of SHP-1.
Martin A; Tsui HW; Shulman MJ; Isenman D; Tsui FW
J Biol Chem; 1999 Jul; 274(31):21725-34. PubMed ID: 10419485
[TBL] [Abstract][Full Text] [Related]
6. SHP-1 suppresses cancer cell growth by promoting degradation of JAK kinases.
Wu C; Guan Q; Wang Y; Zhao ZJ; Zhou GW
J Cell Biochem; 2003 Dec; 90(5):1026-37. PubMed ID: 14624462
[TBL] [Abstract][Full Text] [Related]
7. Lack of phosphotyrosine phosphatase SHP-1 expression in malignant T-cell lymphoma cells results from methylation of the SHP-1 promoter.
Zhang Q; Raghunath PN; Vonderheid E; Odum N; Wasik MA
Am J Pathol; 2000 Oct; 157(4):1137-46. PubMed ID: 11021818
[TBL] [Abstract][Full Text] [Related]
8. Src homology 2 domain-containing protein-tyrosine phosphatases, SHP-1 and SHP-2, are required for platelet endothelial cell adhesion molecule-1/CD31-mediated inhibitory signaling.
Henshall TL; Jones KL; Wilkinson R; Jackson DE
J Immunol; 2001 Mar; 166(5):3098-106. PubMed ID: 11207261
[TBL] [Abstract][Full Text] [Related]
9. SHP-1 expression in peripheral T cells from patients with Sezary syndrome and in the T cell line HUT-78: implications in JAK3-mediated signaling.
León F; Cespón C; Franco A; Lombardía M; Roldán E; Escribano L; Harto A; González-Porqué P; Roy G
Leukemia; 2002 Aug; 16(8):1470-7. PubMed ID: 12145687
[TBL] [Abstract][Full Text] [Related]
10. Human 70-kDa SHP-1L differs from 68-kDa SHP-1 in its C-terminal structure and catalytic activity.
Jin YJ; Yu CL; Burakoff SJ
J Biol Chem; 1999 Oct; 274(40):28301-7. PubMed ID: 10497187
[TBL] [Abstract][Full Text] [Related]
11. The lymphoid protein tyrosine phosphatase Lyp interacts with the adaptor molecule Grb2 and functions as a negative regulator of T-cell activation.
Hill RJ; Zozulya S; Lu YL; Ward K; Gishizky M; Jallal B
Exp Hematol; 2002 Mar; 30(3):237-44. PubMed ID: 11882361
[TBL] [Abstract][Full Text] [Related]
12. Expression of dominant-negative src-homology domain 2-containing protein tyrosine phosphatase-1 results in increased Syk tyrosine kinase activity and B cell activation.
Dustin LB; Plas DR; Wong J; Hu YT; Soto C; Chan AC; Thomas ML
J Immunol; 1999 Mar; 162(5):2717-24. PubMed ID: 10072516
[TBL] [Abstract][Full Text] [Related]
13. Targeting Src homology 2 domain-containing tyrosine phosphatase (SHP-1) into lipid rafts inhibits CD3-induced T cell activation.
Su MW; Yu CL; Burakoff SJ; Jin YJ
J Immunol; 2001 Mar; 166(6):3975-82. PubMed ID: 11238643
[TBL] [Abstract][Full Text] [Related]
14. Characterization of SHP-1 protein tyrosine phosphatase transcripts, protein isoforms and phosphatase activity in epithelial cancer cells.
Evren S; Wan S; Ma XZ; Fahim S; Mody N; Sakac D; Jin T; Branch DR
Genomics; 2013; 102(5-6):491-9. PubMed ID: 24100145
[TBL] [Abstract][Full Text] [Related]
15. SHP-1 variant proteins are absent in motheaten mice despite presence of splice variant transcripts with open reading frames.
Martin A; Tsui HW; Tsui FW
Mol Immunol; 1999; 36(15-16):1029-41. PubMed ID: 10698306
[TBL] [Abstract][Full Text] [Related]
16. CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A.
Shlapatska LM; Mikhalap SV; Berdova AG; Zelensky OM; Yun TJ; Nichols KE; Clark EA; Sidorenko SP
J Immunol; 2001 May; 166(9):5480-7. PubMed ID: 11313386
[TBL] [Abstract][Full Text] [Related]
17. The phosphotyrosine phosphatase SHP-2 participates in a multimeric signaling complex and regulates T cell receptor (TCR) coupling to the Ras/mitogen-activated protein kinase (MAPK) pathway in Jurkat T cells.
Frearson JA; Alexander DR
J Exp Med; 1998 May; 187(9):1417-26. PubMed ID: 9565634
[TBL] [Abstract][Full Text] [Related]
18. The function of the protein tyrosine phosphatase SHP-1 in cancer.
Wu C; Sun M; Liu L; Zhou GW
Gene; 2003 Mar; 306():1-12. PubMed ID: 12657462
[TBL] [Abstract][Full Text] [Related]
19. Positive regulation of c-Jun N-terminal kinase and TNF-alpha production but not histamine release by SHP-1 in RBL-2H3 mast cells.
Xie ZH; Zhang J; Siraganian RP
J Immunol; 2000 Feb; 164(3):1521-8. PubMed ID: 10640770
[TBL] [Abstract][Full Text] [Related]
20. The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors.
Wu CJ; O'Rourke DM; Feng GS; Johnson GR; Wang Q; Greene MI
Oncogene; 2001 Sep; 20(42):6018-25. PubMed ID: 11593409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
